Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmethylphenidate extended-release observational study in children with ADHD
ChiCTR2600135131Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmethylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Shanghai Children's Hospital. Primary endpoint: Change in total SNAP-IV score from baseline at Week 12. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
dexmethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on ChiCTR2600135131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135131.